» Articles » PMID: 36448728

Prebiotic Oligofructose Protects Against High-fat Diet-induced Obesity by Changing the Gut Microbiota, Intestinal Mucus Production, Glycosylation and Secretion

Overview
Journal Gut Microbes
Date 2022 Nov 30
PMID 36448728
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a major risk factor for the development of type 2 diabetes and cardiovascular diseases, and gut microbiota plays a key role in influencing the host energy homeostasis. Moreover, obese mice have a different gut microbiota composition, associated with an alteration of the intestinal mucus layer, which represents the interface between the bacteria and the host. We previously demonstrated that prebiotic treatment with oligofructose (FOS) counteracted the effects of diet-induced obesity, together with changes in the gut microbiota composition, but it is not known if the intestinal mucus layer could be involved. In this study, we found that, in addition to preventing high-fat diet (HFD) induced obesity in mice, the treatment with FOS increased the expression of numerous genes involved in mucus production, glycosylation and secretion, the expression of both secreted and transmembrane mucins, and the differentiation and number of goblet cells. These results were associated with significant changes in the gut microbiota composition, with FOS significantly increasing the relative and absolute abundance of the bacterial genera , two unknown and an unknown . Interestingly, all these bacterial genera had a negative association with metabolic parameters and a positive association with markers of the mucus layer. Our study shows that FOS treatment is able to prevent HFD-induced metabolic disorders, at least in part, by acting on all the processes of the mucus production. These data suggest that targeting the mucus and the gut microbiota by using prebiotics could help to prevent or mitigate obesity and related disorders.

Citing Articles

Single, but not mixed dietary fibers suppress body weight gain and adiposity in high fat-fed mice.

Shallangwa S, Ross A, Morgan P Front Microbiol. 2025; 16:1544433.

PMID: 40012787 PMC: 11861375. DOI: 10.3389/fmicb.2025.1544433.


Early enteral nutrition with fructooligosaccharides improves prognosis in severe acute pancreatitis.

Liu F, Xiao Z, Zeng H, Li J, Ai F, Qi J Sci Rep. 2025; 15(1):5267.

PMID: 39939635 PMC: 11822058. DOI: 10.1038/s41598-025-89739-x.


High-fat diet promotes gestational diabetes mellitus through modulating gut microbiota and bile acid metabolism.

Yao L, Zhou X, Jiang X, Chen H, Li Y, Xiong X Front Microbiol. 2025; 15:1480446.

PMID: 39935515 PMC: 11810896. DOI: 10.3389/fmicb.2024.1480446.


Wet pulverization combined with temperature cycling strategy for extraction of protein with attenuating hepatic steatosis on obese mice.

Liu P, Gao C, Li W, Chen W, Zhang Z, Wu D Food Chem X. 2025; 25:102170.

PMID: 39897974 PMC: 11782863. DOI: 10.1016/j.fochx.2025.102170.


Effects of prebiotics from diverse sources on dysbiotic gut microbiota associated to western diet: Insights from the human Mucosal ARtificial COLon (M-ARCOL).

Uriot O, Defois-Fraysse C, Couturier I, Deschamps C, Durif C, Chaudemanche C Curr Res Food Sci. 2025; 10():100968.

PMID: 39834797 PMC: 11743849. DOI: 10.1016/j.crfs.2024.100968.


References
1.
Schroeder B, Birchenough G, Pradhan M, Nystrom E, Henricsson M, Hansson G . Obesity-associated microbiota contributes to mucus layer defects in genetically obese mice. J Biol Chem. 2020; 295(46):15712-15726. PMC: 7667970. DOI: 10.1074/jbc.RA120.015771. View

2.
Bafna S, Kaur S, Batra S . Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010; 29(20):2893-904. PMC: 2879972. DOI: 10.1038/onc.2010.87. View

3.
Everard A, Lazarevic V, Derrien M, Girard M, Muccioli G, Muccioli G . Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 2011; 60(11):2775-86. PMC: 3198091. DOI: 10.2337/db11-0227. View

4.
Cani P, Daubioul C, Reusens B, Remacle C, Catillon G, Delzenne N . Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol. 2005; 185(3):457-65. DOI: 10.1677/joe.1.06100. View

5.
Cani P, Neyrinck A, Fava F, Knauf C, Burcelin R, Tuohy K . Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007; 50(11):2374-83. DOI: 10.1007/s00125-007-0791-0. View